SCHEMBL3719698

SCHEMBL3719698

N=C(N)N(CCCCCCOc1ccc(Cl)cc1)c1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ HRH3 Q9Y5N1 2/20 0.47
▸ HRH4 Q9H3N8 1/20 0.47
▸ PRMT1 Q99873 3/20 0.43
▸ F2 P00734 2/20 0.43
▸ ST14 Q9Y5Y6 2/20 0.43
▸ PLAU P00749 1/20 0.43
▸ PRMT5 O14744 1/20 0.43
▸ SLC22A2 O15244 1/20 0.43
▸ SLC22A1 O15245 1/20 0.43
▸ TMPRSS2 O15393 1/20 0.43
▸ PTP4A3 O75365 1/20 0.43
▸ SLC22A3 O75751 1/20 0.43
▸ F10 P00742 1/20 0.43
▸ PLG P00747 1/20 0.43
▸ S100B P04271 1/20 0.43
▸ CHRM2 P08172 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10600686 0.77 CYP2D6 (0.41) CYP2C19CYP2D6OPRM1GRIN1KCNH2
Hydrochloric Acid SCHEMBL3725099 0.72 HRH3 (0.47) HRH3HRH4PRMT1F2ST14
SCHEMBL7147886 0.71 HRH3 (0.48) HRH3HRH4PRMT1F2ST14
Iodide SCHEMBL3719395 0.70 HRH3 (0.47) HRH3HRH4PRMT1F2ST14
SCHEMBL3744394 0.68 SIGMAR1 (0.43) CYP3A4CYP2C19HRH3HRH4PLAU
SCHEMBL30514014 0.67 HRH3 (0.61) HRH3DRD3KCNH2ALDH1A1
SCHEMBL11815991 0.67 HRH3 (0.61) HRH3DRD3KCNH2ALDH1A1
SCHEMBL9770302 0.66 ALDH3A1 (0.62) HRH3DRD3KCNH2ALDH1A1
SCHEMBL3660756 0.66 NAMPT (0.52) HRH3PRMT1F2ST14PLAU
SCHEMBL1820546 0.64 PRMT1 (0.86) HRH3PRMT1F2ST14PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2197443-A2 COMPOSITIONS AND METHODS FOR EFFECTING NAD+ LEVELS USING A NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE INHIBITOR Gemin X Pharmaceuticals Canada Inc. (CA) 2010-06-23 — — EP claimed
WO-2009072004-A2 COMPOSITIONS AND METHODS FOR EFFECTING NAD+ LEVELS USING A NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE INHIBITOR GEMIN X PHARMACEUTICALS CANADA, INC. (US) 2009-06-11 — — WO claimed
EP-2197443-A2 COMPOSITIONS AND METHODS FOR EFFECTING NAD+ LEVELS USING A NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE INHIBITOR Gemin X Pharmaceuticals Canada Inc. (CA) 2010-06-23 — — EP disclosed
WO-2009072004-A2 COMPOSITIONS AND METHODS FOR EFFECTING NAD+ LEVELS USING A NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE INHIBITOR GEMIN X PHARMACEUTICALS CANADA, INC. (US) 2009-06-11 — — WO disclosed
Send feedback